NSIM
FBIO icon

North Star Investment Management’s Fortress Biotech FBIO Stock Holding History

North Star Investment Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13
Closed -$1K – 1061
2020
Q4 		$1K Buy
+13
New +$563 ﹤0.01% 990

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

North Star Investment Management's FBIO Position: Q1 2021 in Review

North Star Investment Management sold out of Fortress Biotech (FBIO) in Q1 2021, closing a stake of 13 shares — an estimated $1K sold.

North Star Investment Management first reported a position in FBIO in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 85 funds tracked by Wall St. Rank hold FBIO as of Q1 2021.

  • North Star Investment Management reported no remaining Fortress Biotech position as of Q1 2021 after selling out during the quarter.
  • North Star Investment Management sold 13 Fortress Biotech shares in Q1 2021, an estimated $1K.
  • North Star Investment Management first reported a position in Fortress Biotech in Q4 2020 and held it in 1 quarter.
  • North Star Investment Management's Fortress Biotech position peaked at $1K in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2021.

Based on North Star Investment Management's 13F filing for Q1 2021, filed 19 Apr 2021.